Squarepoint
IMMU

Squarepoint’s Immunomedics Inc IMMU Stock Holding History

Squarepoint’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-105,318
Closed -$3.73M – 3007
2020
Q2 		$3.73M Sell
105,318
-111,985
-52% -$3.27M 0.06% 427
2020
Q1 		$2.93M Buy
+217,303
New +$3.66M 0.07% 339
2019
Q4 		– Sell
-61,264
Closed -$812K – 2950
2019
Q3 		$812K Buy
+61,264
New +$901K 0.01% 1367
2019
Q2 		– Sell
-130,813
Closed -$2.51M – 2789
2019
Q1 		$2.51M Buy
130,813
+75,383
+136% +$1.22M 0.03% 679
2018
Q4 		$791K Sell
55,430
-16,970
-23% -$337K 0.01% 1022
2018
Q3 		$1.51M Buy
72,400
+6,350
+10% +$150K 0.02% 818
2018
Q2 		$1.56M Buy
66,050
+27,425
+71% +$551K 0.02% 714
2018
Q1 		$564K Buy
38,625
+1,321
+4% +$21.6K 0.01% 1049
2017
Q4 		$603K Buy
37,304
+11,124
+42% +$131K 0.01% 1093
2017
Q3 		$366K Buy
26,180
+10,900
+71% +$109K 0.01% 1090
2017
Q2 		$135K Buy
+15,280
New +$107K ﹤0.01% 1372
2017
Q1 		– Sell
-35,471
Closed -$130K – 2076
2016
Q4 		$130K Buy
35,471
+22,646
+177% +$67K 0.01% 1578
2016
Q3 		$42K Buy
+12,825
New +$35.9K ﹤0.01% 973

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Squarepoint's IMMU Position: Q3 2020 in Review

Squarepoint sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 105,318 shares — an estimated $3.73M sold.

Squarepoint first reported a position in IMMU in Q3 2016 and held it in 13 quarters. The position peaked at $3.73M in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Squarepoint reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Squarepoint sold 105,318 Immunomedics Inc shares in Q3 2020, an estimated $3.73M.
  • Squarepoint first reported a position in Immunomedics Inc in Q3 2016 and held it in 13 quarters.
  • Squarepoint's Immunomedics Inc position peaked at $3.73M in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.